知镜 Cognispect · 医学文献与研究工作台

N-acetyltransferase 10 regulates chemokine expression in keratinocytes and promotes atopic dermatitis.

Shao J, Wang L, Ye Z, Wang K, Shen Z, Hong Z, Sun R, Zhang L, Liu F, Zhang S, Chen Y, Xie Z, Zhang L.
Cell chemical biology · 2026-07-22 · PMID 42486090

文献摘要

Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disorder with complex immunological underpinnings, yet the role of the RNA acetyltransferase NAT10 in its pathogenesis remains unclear. We investigated NAT10 function through cutaneous NAT10 knockdown (microneedle-delivered AAV-shRNA) and pharmacological inhibition (Remodelin), using 2,4-dinitrochlorobenzene- and ovalbumin-induced murine AD models combined with IFN-γ/TNF-α-stimulated HaCaT keratinocytes. Results showed elevated NAT10 expression and acetylcytidine modification in AD keratinocytes. NAT10 knockdown ameliorated skin pathology, reduced serum IgE, and selectively limited neutrophil infiltration by suppressing chemokines (CXCL8, CCL5, CXCL9, CXCL10, CCL2), whereas its overexpression promoted their expression. Mechanistically, NAT10 stabilized RELB mRNA via acetylcytidine modification, thereby activating NF-κB signaling. Remodelin suppressed keratinocyte chemokine production and neutrophil recruitment, improving skin lesions without toxicity. Collectively, NAT10 emerges as a central regulator of keratinocyte-driven inflammation and a viable therapeutic target in AD.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。